NeoGenomics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NeoGenomics and other ETFs, options, and stocks.About NEO
NeoGenomics, Inc. is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. The company was founded by Michael T.
NEO Key Statistics
Stock Snapshot
With a market cap of 2.05B, NeoGenomics(NEO) trades at $15.90. The stock has a price-to-earnings ratio of -39.41.
On 2026-08-19, NeoGenomics(NEO) stock traded between a low of $15.75 and a high of $16.30. Shares are currently priced at $15.90, which is +1.0% above the low and -2.5% below the high.
The NeoGenomics(NEO)'s current trading volume is 920.89K, compared to an average daily volume of 1.57M.
In the last year, NeoGenomics(NEO) shares hit a 52-week high of $16.92 and a 52-week low of $5.94.
In the last year, NeoGenomics(NEO) shares hit a 52-week high of $16.92 and a 52-week low of $5.94.
NEO News
NeoGenomics Inc. ((NEO)) has held its Q2 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks Unlock powerful investing tools with...
Anyone interested in NeoGenomics, Inc. ( ) should probably be aware that the Senior VP & Chief Accounting Officer, Gregory Aunan, recently divested US$321k wort...
Analyst ratings
67%
of 12 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.